All lobbying filings
AVIVA STRATEGIES (FKA MGB CONSULTING)
AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q4 report for TAYSHA GENE THERAPIES on January 15, 2026, reporting no lobbying activity.
Lobbying for TAYSHA GENE THERAPIES · biotechnology
Filing · LD-2 quarterly report
Q4 reportNo activity
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Texas
Lobbying activity
0
No itemized activity in this filing.